Page 26 - JCTR-11-5
P. 26

Journal of Clinical and
            Translational Research                                                AI and LLMs in iPSC cardiac research



            real-time, patient-specific insights—especially when   Consent for publication
            integrated  with  iPSC-CM  platforms  and  longitudinal
            health data. Critical gaps remain in model reproducibility,   Not applicable.
            equity in data representation, and clinical translation—  Availability of data
            particularly in low-resource settings and non-Western
            genomic  contexts.  To  move from  theoretical potential   Not applicable.
            to clinical practice, the field must prioritize federated
            learning, interdisciplinary education, ethical model design,    References
            and globally inclusive infrastructures that decentralize   1.   Di Cesare M, Perel P, Taylor S, et al. The heart of the world.
            innovation and democratize access.                    Global Heart. 2024;19(1):11.
            4.4. Final reflection on AI in the service of empathy     doi: 10.5334/gh.1288
                                                               2.   World Health Organization: WHO. Cardiovascular Diseases
            The  integration  of  LLMs  into regenerative  cardiology   (CVDs); 2021. Available from: https://www.who.int/news-
            offers  a  powerful  means  to  enhance  clinical  precision   room/fact-sheets/detail/cardiovascular-diseases-(cvds)
            and therapeutic foresight. Rather than replacing human   [Last accessed on 2025 May 20].
            judgment, these systems are designed to augment
            clinicians’ capabilities—supporting nuanced interpretation   3.   Hussain MA, Mamun AA, Peters SA, Woodward M,
                                                                  Huxley RR. The burden of cardiovascular disease attributable
            and broader reach. As medicine enters an era shaped by   to major modifiable risk factors in Indonesia. J Epidemiol.
            both molecular insight and computational intelligence, a   2016;26(10):515-521.
            balanced and ethically guided approach is essential.
                                                                  doi: 10.2188/jea.je20150178
              The success of LLMs in cardiovascular applications
            will depend not only on their technical performance but   4.   Pratama DA, Anisah M, Marlianda SA. Real-Time changes
                                                                  of heart rhythm using MATLAB.  Int J Res Vocat Stud.
            also on their alignment with human  values. Empathy,   2023;3(2):53-59.
            transparency, and accountability must remain central,
            ensuring that these models are developed and deployed in      doi: 10.53893/ijrvocas.v3i2.202
            ways that respect patient agency and clinical nuance.  5.   Maddox KEJ, Elkind MSV, Aparicio HJ, et al. Forecasting
                                                                  the burden of cardiovascular disease and stroke in the
            Acknowledgments                                       United States through 2050-Prevalence of Risk Factors and
                                                                  Disease: A Presidential advisory from the American Heart
            None.
                                                                  Association. Circulation. 2024;150(4):e65-e88.
            Funding                                               doi: 10.1161/cir.0000000000001256

            None.                                              6.   Zhu M, Jin W, He W, Zhang L. The incidence, mortality
                                                                  and disease burden of cardiovascular diseases in China:
            Conflict of interest                                  A comparative study with the United States and Japan based
                                                                  on the GBD 2019 time trend analysis. Front Cardiovasc Med.
            Tadahisa Sugiura is an Editorial Board Member of this   2024;11:1408487.
            journal and Guest Editor of this special issue, but was not in
            any way involved in the editorial and peer-review process      doi: 10.3389/fcvm.2024.1408487
            conducted for this paper, directly or indirectly. Separately,   7.   Singh R, Chandi SK, Sran S,  et  al. Emerging therapeutic
            other authors declared that they have no known competing   strategies in cardiovascular diseases. Cureus. 2024;16:e64388.
            financial interests or personal relationships that could have      doi: 10.7759/cureus.64388
            influenced the work reported in this paper.
                                                               8.   Ullah A, Kumar M, Sayyar M,  et al. Revolutionizing
            Author contributions                                  cardiac care: A comprehensive narrative review of cardiac
                                                                  rehabilitation and the evolution of cardiovascular medicine.
            Conceptualization:  Dhienda  C.  Shahannaz, Tadahisa   Cureus. 2023;15:e46469.
               Sugiura                                            doi: 10.7759/cureus.46469
            Writing–original draft: Dhienda C. Shahannaz, Tadahisa
               Sugiura                                         9.   World Heart Federation. CVD Prevention What we Do World
            Writing–review & editing: All authors                 Heart Federation. World Heart Federation; 2024. Available
                                                                  from:    https://world-heart-federation.org/what-we-do/
            Ethics approval and consent to participate            prevention/#:~:text=The%20majority%20of%20deaths%20
                                                                  due,regular%20exercise%20and%20avoiding%20tobacco
            Not applicable.                                       [Last accessed on 2025 May 20].


            Volume 11 Issue 5 (2025)                        20                         doi: 10.36922/JCTR025230026
   21   22   23   24   25   26   27   28   29   30   31